CLEARED PAYMENT REQUIREDNo order is fulfilled before payment verification and order review
KCC LABSScience · Quality · Research
Cart0
ENES

Illustrative chrome-paper vial, not inventory photography. Supplied label claims are not verified analytical results.

Comparative research set

CJC-1295 / Ipamorelin (No DAC) Comparative Research Set

Research area under review

KCC-CJCIPA-PLAN

Specification pending

Set contents: CJC-1295 (No DAC) + Ipamorelin

Planned catalog material. Amount, pricing, stock, identity and lot documentation await confirmation. Not available for ordering.

Release status Coming soon

Coming soon

Catalog priceComing soon
Before you order

Current payment methods: PayPal · Cash App · Zelle

Shipping is limited to eligible U.S. destinations. Shipping and applicable tax are calculated after you enter your address and select delivery, before you pay. Payment and order details must be verified before fulfillment; carrier delivery times are separate.

Images are packaging concepts, not photographs of actual inventory or evidence of a lot’s documentation.

Shipping policy → · Returns & claims policy → · Need help? →

For laboratory research use only. Not for human or veterinary use.

KCC-CJCIPA-PLAN · PRE-LAUNCHSpecification pending Coming soon
COAs ↓
01ReleasePending independent release
02Latest lotComing soon
03DocumentationCOA pending
04EligibilityQualified laboratory research
01

IDENTITY & SPECIFICATIONS

Exact identity first.

Catalog number
KCC-CJCIPA-PLAN
Material identity
CJC-1295 / Ipamorelin (No DAC) Comparative Research Set
Nominal amount
Specification pending
Material type
Comparative research set
Set composition
CJC-1295 (No DAC) + Ipamorelin
Use classification
Laboratory research use only
LITERATURE REFERENCE

Molecular identity

Published structural information for research review—not measured results, a certificate of analysis, or confirmation of a KCC lot’s identity. Match the exact form to released supplier and lot documentation before use.

Component references only. A blend has no single peptide sequence, molecular formula, molecular weight or CAS number. Ratios, compatibility and combined stability require formulation-specific documentation.

CJC-1295 without DAC / Modified GRF(1–29)

Parent compound; counterions and hydration excluded

Reference sequence / structural notationY-{D-Ala}-DAIFTQSYRKVLAQLSARKLLQDILSR-NH2
Backbone residues
29
Reference formula
C152H252N44O42
Reference molecular weight
3367.9 g/mol
Reference CAS
Not assigned to this form

Modified GRF(1–29), without the drug affinity complex (DAC). D-Ala2 and the other substitutions distinguish it from sermorelin. Values exclude acetate; no DAC-form CAS is substituted.

    Ipamorelin

    Parent compound; counterions and hydration excluded

    Reference sequence / structural notationAib-His-D-2-Nal-D-Phe-Lys-NH2
    Backbone residues
    5
    Reference formula
    C38H49N9O5
    Reference molecular weight
    711.9 g/mol
    Reference CAS
    Not assigned to this form

    Noncanonical Aib and D-2-naphthylalanine residues, D-Phe and a C-terminal amide. Values exclude the variable acetate in the cited record.

      How to read the notation

      Sequences run from N to C. Ac = acetyl; -NH2 = C-terminal amide; -OH = free C-terminal acid; D- marks stereochemistry; Aib = α-aminoisobutyric acid; Nle = norleucine; pGlu = pyroglutamate; γ-Glu = gamma-glutamyl linkage; AEEA = 2-[2-(2-aminoethoxy)ethoxy]acetic acid. Lipid linkers and ring closures are described separately. Molecular weights are reference molar masses, not measured MS peaks or per-vial amounts.

      Reference review: September 6, 2026 · Research use only

      02

      RESEARCH CONTEXT

      Research areas & sources.

      Research area under review

      The research classification for this material is awaiting literature review.

      These references explain the research classification. They are not evidence of testing, purity, safety, or efficacy for a KCC Labs product or lot, and do not authorize human or veterinary use.

      03

      AVAILABLE LOTS

      Release-specific status.

      No approved COA is published for this material yet.

      Check this material's current availability and documentation status. Documentation-pending purchases require acknowledgment; an approved COA is published only after release review.

      04

      ANALYTICAL DOCUMENTS

      Evidence tied to the lot.

      No approved analytical document is publicly linked yet.

      A generic certificate is not evidence for this material. Published COAs must correspond to the exact released batch.

      Review the quality framework →
      05

      STORAGE & HANDLING

      Follow the applicable COA and documentation.

      Storage, handling, physical form, and stability conditions may vary by material and lot. Use only the instructions supplied with the released documentation and your institution’s approved laboratory procedures. Do not rely on third-party clinical or administration protocols.

      What the lab record should establish

      Documentation guide—not a claim that these assays have been performed. Only the approved document for the exact lot can establish results. An absent report means no result is published, not that a test passed.

      Identity & structure
      Mass spectrometry / LC–MS and sequence or structural confirmation, as applicable.
      Purity & content
      Lot-specific chromatogram, method and purity result; net compound content reported separately from chromatographic area percentage.
      Chemical form & impurities
      Counterion, hydration, residual solvents and relevant elemental impurities, where characterized.
      Handling & traceability
      Exact lot, SDS, physical form, storage conditions and supported retest or expiry date. Microbiological or endotoxin results only when applicable and documented.